Background: Fatty acids are classified as short-chain (SCFA), medium-chain (MCFA) or long-chain and hold promise as adjunctive chemotherapeutic agents for the treatment of colorectal cancer. The antineoplastic potential of MCFA remains underexplored; accordingly, we compared the MCFA lauric acid (C12:0) to the SCFA butyrate (C4:0) in terms of their capacity to induce apoptosis, modify glutathione (GSH) levels, generate reactive oxygen species (ROS), and modify phases of the cell cycle in Caco-2 and IEC-6 intestinal cell lines. Methods: Caco-2 and IEC-6 cells were treated with lauric acid, butyrate, or vehicle controls. Apoptosis, ROS, and cell cycle analysis were determined by flow cytometry. GSH availability was assessed by enzymology. Results: Lauric acid induced apoptosis in Caco-2 (p < 0.05) and IEC-6 cells (p < 0.05) compared to butyrate. In Caco-2 cells, lauric acid reduced GSH availability and generated ROS compared to butyrate (p < 0.05). Lauric acid reduced Caco-2 and IEC-6 cells in G0/G1and arrested cells in the S and G2/M phases. Lauric acid induced apoptosis in IEC-6 cells compared to butyrate (p < 0.05). Butyrate protected IEC-6 cells from ROS-induced damage, whereas lauric acid induced high levels of ROS compared to butyrate. Conclusion: Compared to butyrate, lauric acid displayed preferential antineoplastic properties, including induction of apoptosis in a CRC cell line.

Keywords:
Medium-chain fatty acid, Short-chain fatty acid, Colorectal cancer, Caco-2, IEC-6, Apoptosis, Redox, Cell cycle, Glutathione, Reactive oxygen species
1.
Matthews GM, Howarth GS, Butler RN: Short-chain fatty acids induce apoptosis in colon cancer cells associated with changes to intracellular redox state and glucose metabolism. Chemotherapy 2012;58:102-109.
2.
Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA: The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 2002;132:1012-1017.
3.
Fauser JK, Prisciandaro LD, Cummins AG, Howarth GS: Fatty acids as potential adjunctive colorectal chemotherapeutic agents. Cancer Biol Ther 2011;11:724-731.
4.
Matthews GM, Butler RN: Cellular mucosal defense during Helicobacter pylori infection: a review of the role of glutathione and the oxidative pentose pathway. Helicobacter 2005;10:298-306.
5.
Young GP, Hu Y, Le Leu RK, Nyskohus L: Dietary fibre and colorectal cancer: a model for environment-gene interactions. Mol Nutr Food Res 2005;49:571-584.
6.
Beermann C, Jelinek J, Reinecker T, Hauenschild A, Boehm G, Klor HU: Short-term effects of dietary medium-chain fatty acids and n-3 long-chain polyunsaturated fatty acids on the fat metabolism of healthy volunteers. Lipids Health Dis 2003;2:1-10.
7.
Bocca C, Bozzo F, Gabriel L, Miglietta A: Conjugated linoleic acid inhibits Caco-2 cell growth via ERK-MAPK signaling pathway. J Nutr Biochem 2007;18:332-340.
8.
Lima TM, Kanunfre CC, Pompeia C, Verlengia R, Curi R: Ranking the toxicity of fatty acids on Jurkat and Raji cells by flow cytometric analysis. Toxicol In Vitro 2002;16:741-747.
9.
Pajak B, Gajkowska B, Orzechowski A: Sodium butyrate sensitizes human colon adenocarcinoma COLO 205 cells to both intrinsic and TNF-alpha-dependent extrinsic apoptosis. Apoptosis 2009;14:203-217.
10.
Hyzd'alova M, Hofmanova J, Pachernik J, Vaculova A, Kozubik A: The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation. Cytokine 2008;44:33-43.
11.
Buda A, Qualtrough D, Jepson MA, Martines D, Paraskeva C, Pignatelli M: Butyrate downregulates alpha2beta1 integrin: a possible role in the induction of apoptosis in colorectal cancer cell lines. Gut 2003;52:729-734.
12.
Ruemmele FM, Schwartz S, Seidman EG, Dionne S, Levy E, Lentze MJ: Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 2003;52:94-100.
13.
Engelbrecht AM, Toit-Kohn JL, Ellis B, Thomas M, Nell T, Smith R: Differential induction of apoptosis and inhibition of the PI3-kinase pathway by saturated, monounsaturated and polyunsaturated fatty acids in a colon cancer cell model. Apoptosis 2008;13:1368-1377.
14.
Nano JL, Nobili C, Girard-Pipau F, Rampal P: Effects of fatty acids on the growth of Caco-2 cells. Prostaglandins Leukot Essent Fatty Acids 2003;69:207-215.
15.
Kato T, Kolenic N, Pardini RS: Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status. Nutr Cancer 2007;58:178-187.
16.
Lee SH, Yamaguchi K, Kim JS, Eling TE, Safe S, Park Y, et al: Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner. Carcinogenesis 2006;27:972-981.
17.
Toit-Kohn JL, Louw L, Engelbrecht AM: Docosahexaenoic acid induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and p38 MAPK pathways. J Nutr Biochem 2009;20:106-114.
18.
Sun Y, Huang L, Mackenzie GG, Rigas B: Oxidative stress mediates through apoptosis the anticancer effect of phospho-nonsteroidal anti-inflammatory drugs: implications for the role of oxidative stress in the action of anticancer agents. J Pharmacol Exp Ther 2011;338:775-783.
19.
Aw TY: Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine. Am J Clin Nutr 1999;70:557-565.
20.
Rigas B, Sun Y: Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer. Br J Cancer 2008;98:1157-1160.
21.
Conklin KA: Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 2004;3:284-300.
22.
Circu ML, Aw TY: Glutathione and apoptosis. Free Radic Res 2008;42:689-706.
23.
Balendiran GK, Dabur R, Fraser D: The role of glutathione in cancer. Cell Biochem Funct 2004;22:343-352.
24.
Gotoh Y, Noda T, Iwakiri R, Fujimoto K, Rhoads CA, Aw TY: Lipid peroxide-induced redox imbalance differentially mediates Caco-2 cell proliferation and growth arrest. Cell Prolif 2002;35:221-235.
25.
Palomares T, Carames M, Garcia-Alonso I, Alonso-Varona A: Glutathione modulation reverses the growth-promoting effect of growth factors, improving the 5-fluorouracil antitumour response in WiDr colon cancer cells. Anticancer Res 2009;29:3957-3965.
26.
Matthews GM, Howarth GS, Butler RN: Short-chain fatty acid modulation of apoptosis in the Kato III human gastric carcinoma cell line. Cancer Biol Ther 2007;6:1051-1057.
27.
Trigatti BL, Gerber GE: A direct role for serum albumin in the cellular uptake of long-chain fatty acids. Biochem J 1995;308:155-159.
28.
Alexandre J, Batteux F, Nicco C, Chereau C, Laurent A, Guillevin L, et al: Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 2006;119:41-48.
29.
Trayner ID, Rayner AP, Freeman GE, Farzaneh F: Quantitative multiwell myeloid differentiation assay using dichlorodihydrofluorescein diacetate (H2DCF-DA) or dihydrorhodamine 123 (H2R123). J Immunol Methods 1995;186:275-284.
30.
Attene-Ramos M, Kitiphongspattana K, Ishii-Schrade K, Gaskins HR: Temporal changes of multiple redox couples from proliferation to growth arrest in IEC-6 intestinal epithelial cells. Am J Physiol Cell Physiol 2005;289:C1220-C1228.
31.
Sado-Kamdem SL, Vannini L, Guerzoni ME: Effect of alpha-linolenic, capric and lauric acid on the fatty acid biosynthesis in Staphylococcus aureus. Int J Food Microbiol 2009;129:288-294.
32.
Adhikari D, Feroz F, Liefshitz A, Barakat RR, Bertino JR, Banerjee D: Pretreatment of endometrial carcinoma cell lines with butyrate results in upregulation of Bax and correlates with potentiation of radiation induced cell kill. In Vivo 2000;14:603-609.
33.
Litvak DA, Evers BM, Hwang KO, Hellmich MR, Ko TC, Townsend CM Jr: Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1. Surgery 1998;124:161-169, discussion 169-170.
34.
Roy MJ, Dionne S, Marx G, Qureshi I, Sarma D, Levy E, et al: In vitro studies on the inhibition of colon cancer by butyrate and carnitine. Nutrition 2009;25:1193-1201.
35.
Takayama C, Mukaizawa F, Fujita T, Ogawara K, Ogawara K, Kimura T: Amino acids suppress apoptosis induced by sodium laurate, an absorption enhancer. J Pharm Sci 2009;98:4629-4638.
36.
Bartolotta S, Garcia CC, Candurra NA, Damonte EB: Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid. Arch Virol 2001;146:777-790.
37.
Hornung B, Amtmann E, Sauer G: Lauric acid inhibits the maturation of vesicular stomatitis virus. J Gen Virol 1994;75:353-361.
38.
Petschow BW, Batema RP, Ford LL: Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob Agents Chemother 1996;40:302-306.
39.
Kirlin WG, Cai J, Thompson SA, Diaz D, Kavanagh TJ, Jones DP: Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic Biol Med 1999;27:1208-1218.
40.
Pias EK, Aw TY: Apoptosis in mitotic competent undifferentiated cells is induced by cellular redox imbalance independent of reactive oxygen species production. FASEB J 2002;16:781-790.
41.
Noda T, Iwakiri R, Fujimoto K, Aw TY: Induction of mild intracellular redox imbalance inhibits proliferation of Caco-2 cells. FASEB J 2001;15:2131-2139.
42.
Xiang AC, Xie J, Zhang XJ: Acetylcholinesterase in intestinal cell differentiation involves G2/M cell cycle arrest. Cell Mol Life Sci 2008;65:1768-1779.
43.
Jordan A, Stein J: Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2. Eur J Nutr 2003;42:324-331.
44.
Circu ML, Aw TY: Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010;48:749-762.
45.
Muller RH, Radtke M, Wissing SA: Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002;242:121-128.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.